CENTER LABORATORIES, INC. – Trademark Portfolio

Entity Type: 03

CENTER LABORATORIES, INC. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 9 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CENTER-AL. The owner is based in PORT WASHINGTON, NY.

CHANNEL DRIVE

PORT WASHINGTON, NY 11050

11 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CENTER LABORATORIES, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (9 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does CENTER LABORATORIES, INC. have?

CENTER LABORATORIES, INC. has 11 U.S. trademarks filed with the USPTO. Of these, 1 registered, 10 cancelled.

What trademark classes does CENTER LABORATORIES, INC. file in?

CENTER LABORATORIES, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are CENTER LABORATORIES, INC.'s most well-known trademarks?

CENTER LABORATORIES, INC.'s registered trademark portfolio includes well-known marks such as CENTER-AL. These are among 1 currently registered trademark in the portfolio.

What is CENTER LABORATORIES, INC.'s trademark registration success rate?

CENTER LABORATORIES, INC. has a 9% trademark registration rate, with 1 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.